Quantity | = | Concentration | x | Volume | x | Molecular Weight |
---|---|---|---|---|---|---|
= | x | x |
1) Click the Molarity Calculation Cart® button.
2) Specify the Concentration and Volume of your desired Molarity.
3) Click Calculate.
4) Your desired Quantity will be calculated and will be put under Quantity: (only for mg)
5) Click Add to Cart and then Proceed to checkout to complete the order. You will receive the quantity as you ordered as solvent-free form.
Alert: If you want to make a solution with a solvent (such DMSO), please add instructions in the notes section (such as 10 nM/1 mL in DMSO) and we will pack and deliver the product as a solution (such as 10 nM solution in 1 mL DMSO). If the product cannot be dissolved in DMSO or you would like to specify your own preferred solvent, please add detailed instructions in the notes section. All solutions must be shipped with an ice bag, costing an additional fee of $20 for S&H.
NCTP01842
Description: Rabbit polyclonal to human EEA1
Application: ELISA, IHC
Reactivity: Human
Catalog #: NCTP01842
$360.00
Warning: Last items in stock!
Availability date:
DESCRIPTION | |
Species Reactivity | Human |
Isotype | IgG |
Immunogen | A peptide corresponding to C terminal of human EEA1 protein. |
Accession # | Q15075 |
Alternative Names | ZFYVE2; Early endosome antigen 1 |
Purification | Purified by antigen affinity column. |
Formulation | Lyophilized power with 2% BSA and 0.02% NaN3 |
Size | 100µg/200µl |
APPLICATION | |
ELISA | 1:10,000 – 1:100,000 |
Immunohistochemistry | 1:100 - 1:500 |
- | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
PREPARATION AND STORAGE | |
Reconstitution | Reconstitute in 200µl of sterile H2O. |
Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
REFERENCES | |
- | Tanaka D, Nagashima K, Sasaki M, et al. Exome sequencing identifies a new candidate mutation for susceptibility to diabetes in a family with highly aggregated type 2 diabetes. Mol. Genet. Metab. 109(1):112-117 (2013). |